Serum Omentin-1 and Carotid Atherosclerosis In Non-Diabetic Chronic Kidney Disease

NCT01701830 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 85

Last updated 2012-10-05

No results posted yet for this study

Summary

The aim of the study is to evaluate whether a low level of serum omentin-1 is associated with carotid atherosclerosis and mediated by inflammation.

Conditions

Sponsors & Collaborators

  • Kocaeli Derince Education and Research Hospital

    lead OTHER

Principal Investigators

  • Erkan SENGUL, MD · Kocaeli Derince Education and Training Hospital

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-10-31
Completion
2013-05-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01701830 on ClinicalTrials.gov